NO20024924L - Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner - Google Patents
Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjonerInfo
- Publication number
- NO20024924L NO20024924L NO20024924A NO20024924A NO20024924L NO 20024924 L NO20024924 L NO 20024924L NO 20024924 A NO20024924 A NO 20024924A NO 20024924 A NO20024924 A NO 20024924A NO 20024924 L NO20024924 L NO 20024924L
- Authority
- NO
- Norway
- Prior art keywords
- hypertrophy
- bradycardial
- substances
- treatment
- connection
- Prior art date
Links
- 208000031229 Cardiomyopathies Diseases 0.000 title abstract 2
- 206010020880 Hypertrophy Diseases 0.000 title abstract 2
- 239000002547 new drug Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- OBUFMJDDZTXJPY-NRFANRHFSA-N 3-[[(3s)-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl]-7,8-dimethoxy-2,5-dihydro-1h-3-benzazepin-4-one Chemical compound C1=C(OC)C(OC)=CC=C1CCN1C[C@@H](CN2C(CC3=CC(OC)=C(OC)C=C3CC2)=O)CCC1 OBUFMJDDZTXJPY-NRFANRHFSA-N 0.000 abstract 2
- 108090000312 Calcium Channels Proteins 0.000 abstract 1
- 102000003922 Calcium Channels Human genes 0.000 abstract 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 abstract 1
- 108091006146 Channels Proteins 0.000 abstract 1
- 241000282326 Felis catus Species 0.000 abstract 1
- 239000002876 beta blocker Substances 0.000 abstract 1
- 230000000059 bradycardiac effect Effects 0.000 abstract 1
- 239000002371 cardiac agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229950010208 cilobradine Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010020871 hypertrophic cardiomyopathy Diseases 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10018401A DE10018401A1 (de) | 2000-04-13 | 2000-04-13 | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
| PCT/EP2001/004034 WO2001078699A2 (de) | 2000-04-13 | 2001-04-07 | Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20024924L true NO20024924L (no) | 2002-10-11 |
| NO20024924D0 NO20024924D0 (no) | 2002-10-11 |
| NO330311B1 NO330311B1 (no) | 2011-03-28 |
Family
ID=7638652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024924A NO330311B1 (no) | 2000-04-13 | 2002-10-11 | Bradykardiale substanser for behandling av myokardiale sykdommer som ledsages av hypertrofi. |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7208508B2 (no) |
| EP (2) | EP1666042A3 (no) |
| JP (1) | JP3905386B2 (no) |
| KR (1) | KR20020089453A (no) |
| CN (1) | CN1245963C (no) |
| AT (1) | ATE330588T1 (no) |
| AU (2) | AU7048401A (no) |
| BG (1) | BG65816B1 (no) |
| BR (1) | BR0109996A (no) |
| CA (2) | CA2404120C (no) |
| CY (1) | CY1105081T1 (no) |
| CZ (1) | CZ300549B6 (no) |
| DE (2) | DE10018401A1 (no) |
| DK (1) | DK1276476T3 (no) |
| EA (1) | EA006977B1 (no) |
| EE (1) | EE05099B1 (no) |
| ES (1) | ES2266216T3 (no) |
| HR (1) | HRP20020815A2 (no) |
| HU (1) | HU228387B1 (no) |
| IL (2) | IL152103A0 (no) |
| ME (1) | MEP45908A (no) |
| MX (1) | MXPA02009935A (no) |
| NO (1) | NO330311B1 (no) |
| NZ (1) | NZ521934A (no) |
| PL (1) | PL215235B1 (no) |
| PT (1) | PT1276476E (no) |
| RS (1) | RS51478B (no) |
| SI (1) | SI1276476T1 (no) |
| SK (1) | SK286075B6 (no) |
| TR (1) | TR200202326T2 (no) |
| UA (1) | UA78679C2 (no) |
| WO (1) | WO2001078699A2 (no) |
| ZA (1) | ZA200208162B (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10018401A1 (de) | 2000-04-13 | 2001-10-25 | Boehringer Ingelheim Pharma | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
| US20040138306A1 (en) * | 2002-07-25 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| DE60200160T2 (de) * | 2002-07-25 | 2004-11-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen |
| JP3874419B2 (ja) * | 2003-01-31 | 2007-01-31 | 三共株式会社 | 動脈硬化及び高血圧症の予防及び治療のための医薬 |
| WO2007001066A1 (en) * | 2005-06-27 | 2007-01-04 | Daiichi Sankyo Company, Limited | Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker |
| JPWO2007023775A1 (ja) * | 2005-08-23 | 2009-02-26 | アステラス製薬株式会社 | 心房細動治療剤 |
| EP1762179A1 (en) * | 2005-09-07 | 2007-03-14 | Boehringer Ingelheim Vetmedica Gmbh | Method for improving diagnostic quality in echocardiography |
| FR2894825B1 (fr) * | 2005-12-21 | 2010-12-03 | Servier Lab | Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent |
| TWI399223B (zh) * | 2006-09-15 | 2013-06-21 | Daiichi Sankyo Co Ltd | 奧美沙坦酯及氨氯地平之固體劑型 |
| EP1908469A1 (en) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| AU2010251194B2 (en) | 2009-05-20 | 2016-02-25 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical oral telmisartan solution |
| FR2961105B1 (fr) * | 2010-06-15 | 2013-02-08 | Servier Lab | Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque |
| KR101296743B1 (ko) * | 2011-02-17 | 2013-08-20 | 한국과학기술연구원 | 심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법 |
| KR20140057604A (ko) | 2011-08-12 | 2014-05-13 | 베링거잉겔하임베트메디카게엠베하 | 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제 |
| WO2014122248A1 (en) | 2013-02-11 | 2014-08-14 | Boehringer Ingelheim Vetmedica Gmbh | Kit-of-parts |
| NZ759782A (en) | 2017-07-07 | 2023-06-30 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
| EP3996709A1 (en) | 2019-07-09 | 2022-05-18 | Boehringer Ingelheim Vetmedica GmbH | Telmisartan for the treatment of hypertension in dogs |
| KR102398532B1 (ko) | 2020-07-20 | 2022-05-13 | 한림대학교 산학협력단 | 중증 지주막하출혈 진단용 조성물 |
| KR102331806B1 (ko) | 2020-07-20 | 2021-12-01 | 한림대학교 산학협력단 | 중증 지주막하출혈 진단용 바이오 마커 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE759125A (fr) | 1969-11-19 | 1971-05-18 | Boehringer Sohn Ingelheim | Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer |
| DE3119874A1 (de) | 1981-05-19 | 1982-12-09 | Dr. Karl Thomae Gmbh, 7950 Biberach | "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel" |
| US5175157A (en) * | 1985-11-27 | 1992-12-29 | Boehringer Ingelheim Gmbh | Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them |
| DE3541811A1 (de) * | 1985-11-27 | 1987-06-04 | Thomae Gmbh Dr K | Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE3736866A1 (de) * | 1987-10-30 | 1989-05-11 | Thomae Gmbh Dr K | Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz |
| DE3805635A1 (de) | 1988-02-24 | 1989-09-07 | Thomae Gmbh Dr K | Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica |
| US5308853A (en) * | 1991-12-20 | 1994-05-03 | Warner-Lambert Company | Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties |
| RU2078536C1 (ru) * | 1993-09-02 | 1997-05-10 | Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско | Способ определения клинической эффективности применения верапамила и дилтиазема у больных гипертрофической кардиомиопатией |
| CZ86796A3 (en) * | 1993-09-24 | 1996-10-16 | Procter & Gamble | Novel deoxy and on oxygen substituted sugar derivatives of aminosteroidal compounds |
| US5595987A (en) * | 1994-07-22 | 1997-01-21 | The Trustees Of Columbia University In The City Of New York | Method of slowing ventricular arrhythmias using zatebradine |
| US6083991A (en) * | 1997-06-04 | 2000-07-04 | University Of Florida Research Foundation, Inc. | Anti-arrhythmic composition and methods of treatment |
| DE19741635A1 (de) * | 1997-09-22 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
| KR20040078140A (ko) | 1998-07-10 | 2004-09-08 | 노파르티스 아게 | 발사르탄 및 칼슘 채널 차단제의 항고혈압 병용 제제 |
| DE10018401A1 (de) * | 2000-04-13 | 2001-10-25 | Boehringer Ingelheim Pharma | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
| US20040138306A1 (en) * | 2002-07-25 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| CA2435526A1 (en) | 2002-07-25 | 2004-01-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| EP1762179A1 (en) * | 2005-09-07 | 2007-03-14 | Boehringer Ingelheim Vetmedica Gmbh | Method for improving diagnostic quality in echocardiography |
-
2000
- 2000-04-13 DE DE10018401A patent/DE10018401A1/de not_active Withdrawn
-
2001
- 2001-04-07 ES ES01949281T patent/ES2266216T3/es not_active Expired - Lifetime
- 2001-04-07 NZ NZ521934A patent/NZ521934A/en not_active IP Right Cessation
- 2001-04-07 EA EA200201053A patent/EA006977B1/ru not_active IP Right Cessation
- 2001-04-07 ME MEP-459/08A patent/MEP45908A/xx unknown
- 2001-04-07 IL IL15210301A patent/IL152103A0/xx unknown
- 2001-04-07 US US10/257,481 patent/US7208508B2/en not_active Expired - Fee Related
- 2001-04-07 HR HRP20020815 patent/HRP20020815A2/hr not_active Application Discontinuation
- 2001-04-07 AU AU7048401A patent/AU7048401A/xx active Pending
- 2001-04-07 CA CA002404120A patent/CA2404120C/en not_active Expired - Fee Related
- 2001-04-07 DK DK01949281T patent/DK1276476T3/da active
- 2001-04-07 JP JP2001576000A patent/JP3905386B2/ja not_active Expired - Fee Related
- 2001-04-07 SI SI200130616T patent/SI1276476T1/sl unknown
- 2001-04-07 HU HU0300917A patent/HU228387B1/hu not_active IP Right Cessation
- 2001-04-07 EP EP06111485A patent/EP1666042A3/de not_active Withdrawn
- 2001-04-07 AU AU2001270484A patent/AU2001270484B2/en not_active Ceased
- 2001-04-07 MX MXPA02009935A patent/MXPA02009935A/es active IP Right Grant
- 2001-04-07 DE DE50110262T patent/DE50110262D1/de not_active Expired - Lifetime
- 2001-04-07 EE EEP200200590A patent/EE05099B1/xx not_active IP Right Cessation
- 2001-04-07 BR BR0109996-5A patent/BR0109996A/pt not_active Application Discontinuation
- 2001-04-07 CN CNB018079598A patent/CN1245963C/zh not_active Expired - Fee Related
- 2001-04-07 TR TR2002/02326T patent/TR200202326T2/xx unknown
- 2001-04-07 PT PT01949281T patent/PT1276476E/pt unknown
- 2001-04-07 RS YUP-769/02A patent/RS51478B/sr unknown
- 2001-04-07 SK SK1458-2002A patent/SK286075B6/sk not_active IP Right Cessation
- 2001-04-07 EP EP01949281A patent/EP1276476B1/de not_active Expired - Lifetime
- 2001-04-07 KR KR1020027013688A patent/KR20020089453A/ko not_active Ceased
- 2001-04-07 CZ CZ20023752A patent/CZ300549B6/cs not_active IP Right Cessation
- 2001-04-07 WO PCT/EP2001/004034 patent/WO2001078699A2/de not_active Ceased
- 2001-04-07 CA CA002575059A patent/CA2575059A1/en not_active Abandoned
- 2001-04-07 AT AT01949281T patent/ATE330588T1/de active
- 2001-04-07 PL PL357827A patent/PL215235B1/pl unknown
- 2001-07-04 UA UA2002118949A patent/UA78679C2/uk unknown
-
2002
- 2002-09-13 BG BG107103A patent/BG65816B1/bg unknown
- 2002-10-03 IL IL152103A patent/IL152103A/en not_active IP Right Cessation
- 2002-10-10 ZA ZA200208162A patent/ZA200208162B/en unknown
- 2002-10-11 NO NO20024924A patent/NO330311B1/no not_active IP Right Cessation
-
2006
- 2006-07-07 CY CY20061100956T patent/CY1105081T1/el unknown
-
2007
- 2007-03-12 US US11/684,974 patent/US20070155679A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL152103A0 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations | |
| AU2005202257C1 (en) | Azacyclic compounds for use in the treatment of serotonin related diseases | |
| ES2164040T1 (es) | Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos. | |
| BE2012C040I2 (no) | ||
| TW200505901A (en) | Muscarinic agonists | |
| BR0010669A (pt) | Método para o tratamento de fibrose usando um antagonista da subunidade alfa-4 da integrina | |
| GB2352972A (en) | Use of dexmedetomidine for icu sedation | |
| PT1900362E (pt) | Derivados de alfa-aminoamida úteis no tratamento de perturbações aditivas | |
| BR9910899A (pt) | Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida | |
| BR0111982A (pt) | Tratamento com apomorfina, de disfunção sexual induzida por droga anti depressão | |
| BR0108261A (pt) | Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono | |
| RU2003130641A (ru) | Каппа-опиатные агонисты для лечения заболеваний мочевого пузыря | |
| NO20005223L (no) | Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen | |
| US6214849B1 (en) | Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function in mammals including humans | |
| EP1632235A3 (en) | Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders | |
| BRPI0414112A (pt) | uso de oxcarbazepina para o tratamento de dor neuropática diabética e a melhora do sono | |
| PL1514545T3 (pl) | Zastosowanie tolperyzonu do leczenia skurczów narządów zbudowanych zasadniczo z mięśni gładkich | |
| Higgins | Reducing GI toxicity of NSAIDs: common goal, different approaches | |
| ECSP003771A (es) | Metodo para prevenir la diarrea | |
| EP1787984A3 (en) | Azacyclic compounds for use in the treatment of serotonin related diseases | |
| BRPI0503488A (pt) | agente de tratamento para sìndrome de intestino irritável com diarréia predominante | |
| RU2002103977A (ru) | Способ лечения острого гнойного пиелонефрита | |
| RU99118112A (ru) | Способ лечения больных с невротическими расстройствами препаратом "миелопид" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |